Zydus Cadila gets tentative USFDA nod to market anti-cancer drug

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Palbociclib Capsules in the strengths of 75 mg, 100 mg, and 125 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3mQ33KH